Skip to main content

Peer Review reports

From: Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer

Original Submission
6 Jul 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
19 Aug 2021 Author responded Author comments - Songjie Shen
Resubmission - Version 3
19 Aug 2021 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
17 Dec 2021 Reviewed Reviewer Report
14 Mar 2022 Reviewed Reviewer Report - Ruana Rocha
29 Mar 2022 Author responded Author comments - Songjie Shen
Resubmission - Version 5
29 Mar 2022 Submitted Manuscript version 5
31 Mar 2022 Author responded Author comments - Songjie Shen
Resubmission - Version 6
31 Mar 2022 Submitted Manuscript version 6
10 Apr 2022 Reviewed Reviewer Report
10 May 2022 Reviewed Reviewer Report - Ruana Rocha
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
11 May 2022 Editorially accepted
14 May 2022 Article published 10.1186/s12885-022-09656-4

You can find further information about peer review here.

Back to article page